Clinical Trial Update: The Peripheral Mobilized Mononuclear Cell-based Therapy in Patient With Diabetic Neuropathy [NA]

View source ↗

Summary

A clinical trial of a peripheral mobilized mononuclear cell–based therapy for diabetic neuropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Peripheral Mobilized Mononuclear Cell-based Therapy

Snippet

Sponsor: Seoul National University Hospital | Conditions: Diabetic Neuropathy | NA | Status: WITHDRAWN